View DividendLenzing 경영진경영진 기준 점검 1/4현재 CEO에 대한 정보가 충분하지 않습니다.핵심 정보 최고경영자n/a총 보수CEO 급여 비율n/aCEO 재임 기간no dataCEO 지분 보유율n/a경영진 평균 재임 기간less than a year이사회 평균 재임 기간3.1yrs최근 경영진 업데이트공시 • Dec 09Lenzing Aktiengesellschaft, Annual General Meeting, Apr 23, 2026Lenzing Aktiengesellschaft, Annual General Meeting, Apr 23, 2026.공시 • Apr 18Lenzing Announces Supervisory Board ChangesLenzing at its annual general meeting, appointed Patrick Lackenbucher and Leonardo Grimaldi to the supervisory board until 2029. They replace Cord Prinzhorn, whose term expired, and Marcelo Feriozzi Bacci, who resigned from the board in December 2024, according to a company statement on Thursday.공시 • Apr 03The Lenzing Group Announces Board Member and Chief Transformation Officer Walter Bickel Will Leave Company At the End of March 2025The Lenzing Group announced personnel changes in the company’s Managing Board. The Supervisory Board of Lenzing AG and Dr. Walter Bickel, Chief Transformation Officer of Lenzing AG, have mutually agreed to end the temporary mandate of Mr. Bickel and that Mr. Bickel will step down from his operational activities at the end of March 2025. Mr. Bickel was appointed to the Managing Board of Lenzing AG as of April 15, 2024 to strengthen the Lenzing Managing Board and to be responsible for the further development and implementation of the performance program. Under his leadership, a significant overachievement of the planned contributions from the performance program could be realized. The basis for future significant improvement steps is established, and the program has been structured in a way that it can now be continued by Lenzing AG seamlessly.공시 • Mar 12Cord Prinzhorn Not Stand for Re-Election as Member of Lenzing AG's Supervisory BoardThe Chairman of the Supervisory Board of Lenzing AG, Cord Prinzhorn, has informed the Nomination Committee of the Supervisory Board that he will not extend his term as a member of the company’s Supervisory Board after the Annual General Meeting on April 17, 2025 and will not stand for re-election at the upcoming Annual General Meeting. Cord Prinzhorn intends to devote more time to his existing and new activities at the B&C Group. Mr. Prinzhorn will thus leave the Supervisory Board of Lenzing AG at the end of the Annual General Meeting.공시 • Jan 27Lenzing Aktiengesellschaft, Annual General Meeting, Apr 17, 2025Lenzing Aktiengesellschaft, Annual General Meeting, Apr 17, 2025.공시 • Aug 22Lenzing Aktiengesellschaft Announces CEO ChangesLenzing Aktiengesellschaft announced Stephan Sielaff to leave the company as of August 31, 2024. Rohit Aggarwal will take over the position of CEO as of 1 September 2024. Outgoing Chief Executive Officer Stephan Sielaff will leave the company end of August 2024, by mutual agreement with the Supervisory Board.모든 업데이트 보기Recent updatesNew Risk • May 11New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €215m Forecast net loss in 2 years: €37m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€37m net loss in 2 years). Share price has been volatile over the past 3 months (6.8% average weekly change).Reported Earnings • May 11First quarter 2026 earnings released: EPS: €0.01 (vs €0.12 in 1Q 2025)First quarter 2026 results: EPS: €0.01 (down from €0.12 in 1Q 2025). Revenue: €615.7m (down 11% from 1Q 2025). Net income: €300.0k (down 94% from 1Q 2025). Profit margin: 0% (down from 0.7% in 1Q 2025). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.Price Target Changed • Apr 07Price target decreased by 10.0% to €23.50Down from €26.10, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of €23.05. Stock is down 4.4% over the past year. The company is forecast to post a net loss per share of €1.83 next year compared to a net loss per share of €5.45 last year.Reported Earnings • Mar 20Full year 2025 earnings released: €5.45 loss per share (vs €4.06 loss in FY 2024)Full year 2025 results: €5.45 loss per share (further deteriorated from €4.06 loss in FY 2024). Revenue: €2.60b (down 2.3% from FY 2024). Net loss: €210.3m (loss widened 34% from FY 2024). Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.Major Estimate Revision • Feb 18Consensus EPS estimates fall by 16%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€3.34 to -€3.88 per share. Revenue forecast unchanged at €2.62b. Chemicals industry in Austria expected to see average net income growth of 29% next year. Consensus price target broadly unchanged at €26.10. Share price fell 5.8% to €26.10 over the past week.Breakeven Date Change • Feb 17No longer forecast to breakevenThe 5 analysts covering Lenzing no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of €49.9m in 2027. New consensus forecast suggests the company will make a loss of €60.8m in 2027.공시 • Feb 03Lenzing Aktiengesellschaft (WBAG:LNZ) acquired an additional unknown minority stake in TreeToTextile AB.Lenzing Aktiengesellschaft (WBAG:LNZ) acquired an additional unknown minority stake in TreeToTextile AB on February 2, 2026. The transaction is executed through the issuance of new shares. After the acquisition Lenzing Aktiengesellschaft will own majority stake in TreeToTextile AB. Lenzing Aktiengesellschaft (WBAG:LNZ) completed the acquisition of additional unknown minority stake in TreeToTextile AB on February 2, 2026.Price Target Changed • Dec 29Price target decreased by 11% to €24.50Down from €27.40, the current price target is an average from 4 analysts. New target price is 8.9% above last closing price of €22.50. Stock is down 24% over the past year. The company is forecast to post a net loss per share of €3.34 next year compared to a net loss per share of €4.06 last year.공시 • Dec 09Lenzing Aktiengesellschaft, Annual General Meeting, Apr 23, 2026Lenzing Aktiengesellschaft, Annual General Meeting, Apr 23, 2026.Major Estimate Revision • Oct 01Consensus EPS estimates fall by 38%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€1.37 to -€1.89 per share. Revenue forecast of €2.69b unchanged since last update. Chemicals industry in Austria expected to see average net income growth of 17% next year. Consensus price target broadly unchanged at €28.20. Share price fell 3.7% to €25.80 over the past week.공시 • Sep 02+ 3 more updatesLenzing Aktiengesellschaft to Report Q1, 2026 Results on May 07, 2026Lenzing Aktiengesellschaft announced that they will report Q1, 2026 results on May 07, 2026Major Estimate Revision • Aug 15Consensus EPS estimates fall by 12%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€0.988 to -€1.10 per share. Revenue forecast unchanged at €2.69b. Chemicals industry in Austria expected to see average net income growth of 25% next year. Consensus price target broadly unchanged at €28.60. Share price fell 5.5% to €26.75 over the past week.Price Target Changed • Aug 12Price target decreased by 8.9% to €28.50Down from €31.28, the current price target is an average from 5 analysts. New target price is 7.5% above last closing price of €26.50. Stock is down 13% over the past year. The company is forecast to post a net loss per share of €1.16 next year compared to a net loss per share of €4.06 last year.Reported Earnings • Aug 08Second quarter 2025 earnings released: €1.02 loss per share (vs €1.01 loss in 2Q 2024)Second quarter 2025 results: €1.02 loss per share (further deteriorated from €1.01 loss in 2Q 2024). Revenue: €650.9m (flat on 2Q 2024). Net loss: €39.4m (loss widened 1.0% from 2Q 2024). Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 31% per year and the company’s share price has also fallen by 31% per year.분석 기사 • Aug 01Returns On Capital At Lenzing (VIE:LNZ) Paint A Concerning PictureDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...Major Estimate Revision • Jul 09Consensus EPS estimates fall by 18%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€0.835 to -€0.988 per share. Revenue forecast unchanged at €2.69b. Chemicals industry in Austria expected to see average net income growth of 20% next year. Consensus price target broadly unchanged at €30.95. Share price rose 2.8% to €25.50 over the past week.분석 기사 • Jul 09Lenzing Aktiengesellschaft's (VIE:LNZ) Low P/S No Reason For ExcitementWhen close to half the companies operating in the Chemicals industry in Austria have price-to-sales ratios (or "P/S...Price Target Changed • Jul 08Price target decreased by 7.5% to €30.95Down from €33.45, the current price target is an average from 6 analysts. New target price is 23% above last closing price of €25.10. Stock is down 24% over the past year. The company is forecast to post a net loss per share of €0.99 next year compared to a net loss per share of €4.06 last year.Major Estimate Revision • Jun 17Consensus EPS estimates fall by 38%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€0.604 to -€0.835 per share. Revenue forecast unchanged at €2.70b. Chemicals industry in Austria expected to see average net income growth of 18% next year. Consensus price target down from €33.45 to €31.28. Share price fell 12% to €23.75 over the past week.분석 기사 • Jun 12Does Lenzing (VIE:LNZ) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Major Estimate Revision • Jun 01Consensus EPS estimates fall by 25%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€0.484 to -€0.604 per share. Revenue forecast unchanged at €2.72b. Chemicals industry in Austria expected to see average net income growth of 17% next year. Consensus price target of €33.45 unchanged from last update. Share price was steady at €26.40 over the past week.Reported Earnings • May 13First quarter 2025 earnings released: EPS: €0.12 (vs €0.83 loss in 1Q 2024)First quarter 2025 results: EPS: €0.12 (up from €0.83 loss in 1Q 2024). Revenue: €690.2m (up 4.8% from 1Q 2024). Net income: €4.70m (up €36.7m from 1Q 2024). Profit margin: 0.7% (up from net loss in 1Q 2024). Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 30% per year, which means it has not declined as severely as earnings.공시 • Apr 18Lenzing Announces Supervisory Board ChangesLenzing at its annual general meeting, appointed Patrick Lackenbucher and Leonardo Grimaldi to the supervisory board until 2029. They replace Cord Prinzhorn, whose term expired, and Marcelo Feriozzi Bacci, who resigned from the board in December 2024, according to a company statement on Thursday.분석 기사 • Apr 14Returns On Capital Signal Tricky Times Ahead For Lenzing (VIE:LNZ)If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...공시 • Apr 03The Lenzing Group Announces Board Member and Chief Transformation Officer Walter Bickel Will Leave Company At the End of March 2025The Lenzing Group announced personnel changes in the company’s Managing Board. The Supervisory Board of Lenzing AG and Dr. Walter Bickel, Chief Transformation Officer of Lenzing AG, have mutually agreed to end the temporary mandate of Mr. Bickel and that Mr. Bickel will step down from his operational activities at the end of March 2025. Mr. Bickel was appointed to the Managing Board of Lenzing AG as of April 15, 2024 to strengthen the Lenzing Managing Board and to be responsible for the further development and implementation of the performance program. Under his leadership, a significant overachievement of the planned contributions from the performance program could be realized. The basis for future significant improvement steps is established, and the program has been structured in a way that it can now be continued by Lenzing AG seamlessly.Major Estimate Revision • Apr 02Consensus EPS estimates upgraded to €0.49 lossThe consensus outlook for fiscal year 2025 has been updated. 2025 losses forecast to reduce from -€0.64 to -€0.487 per share. Revenue forecast steady at €2.72b. Chemicals industry in Austria expected to see average net income growth of 17% next year. Consensus price target broadly unchanged at €32.95. Share price fell 15% to €25.90 over the past week.분석 기사 • Mar 15Lenzing Aktiengesellschaft (VIE:LNZ) Surges 35% Yet Its Low P/S Is No Reason For ExcitementLenzing Aktiengesellschaft ( VIE:LNZ ) shares have had a really impressive month, gaining 35% after a shaky period...Reported Earnings • Mar 14Full year 2024 earnings released: €4.06 loss per share (vs €20.02 loss in FY 2023)Full year 2024 results: €4.06 loss per share (improved from €20.02 loss in FY 2023). Revenue: €2.66b (up 5.7% from FY 2023). Net loss: €156.6m (loss narrowed 76% from FY 2023). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 50 percentage points per year, which is a significant difference in performance.공시 • Mar 12Cord Prinzhorn Not Stand for Re-Election as Member of Lenzing AG's Supervisory BoardThe Chairman of the Supervisory Board of Lenzing AG, Cord Prinzhorn, has informed the Nomination Committee of the Supervisory Board that he will not extend his term as a member of the company’s Supervisory Board after the Annual General Meeting on April 17, 2025 and will not stand for re-election at the upcoming Annual General Meeting. Cord Prinzhorn intends to devote more time to his existing and new activities at the B&C Group. Mr. Prinzhorn will thus leave the Supervisory Board of Lenzing AG at the end of the Annual General Meeting.New Risk • Feb 15New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Austrian stocks, typically moving 6.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (6.0% average weekly change).공시 • Jan 27Lenzing Aktiengesellschaft, Annual General Meeting, Apr 17, 2025Lenzing Aktiengesellschaft, Annual General Meeting, Apr 17, 2025.분석 기사 • Jan 14Is Lenzing (VIE:LNZ) A Risky Investment?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...New Risk • Dec 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Austrian stocks, typically moving 4.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (4.6% average weekly change).분석 기사 • Dec 06Investors Don't See Light At End Of Lenzing Aktiengesellschaft's (VIE:LNZ) TunnelWhen you see that almost half of the companies in the Chemicals industry in Austria have price-to-sales ratios (or...Major Estimate Revision • Nov 14Consensus EPS estimates fall by 34%The consensus outlook for fiscal year 2024 has been updated. 2024 expected loss increased from -€2.63 to -€3.51 per share. Revenue forecast unchanged at €2.66b. Chemicals industry in Austria expected to see average net income growth of 35% next year. Consensus price target broadly unchanged at €33.74. Share price fell 5.6% to €29.75 over the past week.Reported Earnings • Nov 08Third quarter 2024 earnings released: €1.66 loss per share (vs €0.97 loss in 3Q 2023)Third quarter 2024 results: €1.66 loss per share (further deteriorated from €0.97 loss in 3Q 2023). Revenue: €647.5m (up 5.2% from 3Q 2023). Net loss: €64.1m (loss widened 45% from 3Q 2023). Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.공시 • Nov 06Lenzing Nonwovens Expands its LENZING Lyocell Dry Fiber Portfolio to Offer Cellulosic Solutions for a Wider Range of ApplicationsLenzing Nonwovens announced the expansion of its LENZING Lyocell Dry fiber portfolio with two new cellulosic fibers – a fine dry fiber that delivers strength and softness and a coarse dry fiber which provides enhanced liquid and air flow. These two innovative products enable customers to confidently broaden their use of LENZING's wood-based and biodegradable fibers into a wider range of applications while maintaining exceptional performance. All LENZING Lyocell Dry fibers within the family (standard, fine, and coarse) have hydrophobic properties which ensure efficient liquid management suitable for extensive nonwoven applications. The new LENZING Lyocell Dry fine fiber can produce nonwoven fabrics with higher density compared to LENZING Lyocell Dry standard fiber. With up to 30% more cellulosic fibers in the same space, customers can create strong and soft nonwoven products. These fibers are suitable for use in hygiene applications such as diapers or sanitary pads. The new LENZING Lyocell Dry coarse fiber creates fabrics that are more open due to its extended fiber diameter, and thus increasing the pore sizes between the fibers in the fabric. This allows for more air or liquid to flow through the material. It is particularly suitable for the acquisition and distribution layer in hygiene products and is also being explored for industrial filtration applications. Lenzing will showcase its innovative LENZING Lyocell Dry fiber family at tabletop 202 during the Hygienix Conference, November 18-21, 2024. Facts and figures: LENZING Lyocell Dry fine has a linear density of 1.3dtex; LENZING Lyocell Dry standard has a linear density of 1.7dtex; Fabrics produced using LENZING Lyocell Dry fine and standard have the same basis weight (eg. 50gsm) but the "fine" material has a higher density with up to 30% more fibers in the same space. LENZING Lyocell Dry coarse has a linear density of 6.3dtex.분석 기사 • Nov 01Lenzing (VIE:LNZ) Might Be Having Difficulty Using Its Capital EffectivelyWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...공시 • Oct 17+ 2 more updatesLenzing Aktiengesellschaft to Report Q3, 2025 Results on Nov 06, 2025Lenzing Aktiengesellschaft announced that they will report Q3, 2025 results on Nov 06, 2025분석 기사 • Sep 20Is Lenzing (VIE:LNZ) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Major Estimate Revision • Sep 01Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2024 has been updated. 2024 expected loss increased from -€1.87 to -€2.07 per share. Revenue forecast unchanged at €2.65b. Chemicals industry in Austria expected to see average net income growth of 30% next year. Consensus price target broadly unchanged at €34.04. Share price fell 3.0% to €30.85 over the past week.공시 • Aug 22Lenzing Aktiengesellschaft Announces CEO ChangesLenzing Aktiengesellschaft announced Stephan Sielaff to leave the company as of August 31, 2024. Rohit Aggarwal will take over the position of CEO as of 1 September 2024. Outgoing Chief Executive Officer Stephan Sielaff will leave the company end of August 2024, by mutual agreement with the Supervisory Board.Major Estimate Revision • Aug 14Consensus EPS estimates fall by 29%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from €2.63b to €2.66b. Forecast EPS reduced from -€1.46 to -€1.87 per share. Chemicals industry in Austria expected to see average net income growth of 30% next year. Consensus price target broadly unchanged at €34.06. Share price was steady at €30.45 over the past week.Reported Earnings • Aug 08Second quarter 2024 earnings released: €1.01 loss per share (vs €0.89 loss in 2Q 2023)Second quarter 2024 results: €1.01 loss per share (further deteriorated from €0.89 loss in 2Q 2023). Revenue: €652.3m (up 4.0% from 2Q 2023). Net loss: €39.0m (loss widened 65% from 2Q 2023). Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance.분석 기사 • Jul 16Lenzing Aktiengesellschaft's (VIE:LNZ) Share Price Is Matching Sentiment Around Its RevenuesLenzing Aktiengesellschaft's ( VIE:LNZ ) price-to-sales (or "P/S") ratio of 0.5x may look like a pretty appealing...분석 기사 • Jun 09Lenzing (VIE:LNZ) Has Debt But No Earnings; Should You Worry?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Price Target Changed • May 14Price target increased by 9.6% to €34.26Up from €31.26, the current price target is an average from 5 analysts. New target price is 5.2% below last closing price of €36.15. Stock is down 34% over the past year. The company is forecast to post a net loss per share of €1.46 next year compared to a net loss per share of €20.02 last year.Reported Earnings • May 09First quarter 2024 earnings released: €0.83 loss per share (vs €3.03 loss in 1Q 2023)First quarter 2024 results: €0.83 loss per share (improved from €3.03 loss in 1Q 2023). Revenue: €658.4m (up 5.7% from 1Q 2023). Net loss: €32.0m (loss narrowed 60% from 1Q 2023). Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.분석 기사 • Apr 16Lenzing Aktiengesellschaft (VIE:LNZ) Stock Catapults 26% Though Its Price And Business Still Lag The IndustryLenzing Aktiengesellschaft ( VIE:LNZ ) shares have had a really impressive month, gaining 26% after a shaky period...Major Estimate Revision • Mar 22Consensus EPS estimates fall by 138%The consensus outlook for fiscal year 2024 has been updated. 2024 expected loss increased from -€0.659 to -€1.57 per share. Revenue forecast unchanged at €2.58b. Chemicals industry in Austria expected to see average net income growth of 19% next year. Consensus price target down from €36.21 to €32.26. Share price was steady at €30.10 over the past week.Price Target Changed • Mar 18Price target decreased by 17% to €32.66Down from €39.20, the current price target is an average from 5 analysts. New target price is 31% above last closing price of €24.85. Stock is down 60% over the past year. The company is forecast to post a net loss per share of €0.30 next year compared to a net loss per share of €20.02 last year.Reported Earnings • Mar 15Full year 2023 earnings released: €20.02 loss per share (vs €2.75 loss in FY 2022)Full year 2023 results: €20.02 loss per share (further deteriorated from €2.75 loss in FY 2022). Revenue: €2.52b (down 1.7% from FY 2022). Net loss: €649.4m (loss widened €576.4m from FY 2022). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.Price Target Changed • Feb 29Price target decreased by 10% to €36.66Down from €40.80, the current price target is an average from 5 analysts. New target price is 27% above last closing price of €28.95. Stock is down 58% over the past year. The company is forecast to post a net loss per share of €9.69 next year compared to a net loss per share of €2.75 last year.분석 기사 • Feb 27Is Lenzing (VIE:LNZ) Using Debt In A Risky Way?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Major Estimate Revision • Feb 09Consensus EPS estimates fall by 28%The consensus outlook for fiscal year 2023 has been updated. 2023 expected loss increased from -€7.59 to -€9.69 per share. Revenue forecast of €2.46b unchanged since last update. Chemicals industry in Austria expected to see average net income growth of 14% next year. Consensus price target down from €40.80 to €39.20. Share price fell 6.3% to €28.15 over the past week.공시 • Feb 01Lenzing Group Teams Up with Recyc Leather and Ganni to Unveil New Footwear MaterialsLenzing Group has partnered with leather alternative expert Recyc Leather to introduce Pelinova, an innovative material that fuses TENCEL™? Lyocell fibers and recycled leather fibers for high-end fashion applications. Joining forces with Danish advanced contemporary brand GANNI, this dynamic trio is set to bring this next-generation material to the market as an alternative to genuine leather materials, starting with GANNI's Slouchy Boots launching early this year. Pelinova: a hybrid alternative combining TENCEL™? L Tokyocell fibers and recycled leather fibers. Recyc Leather's next-generation material, Pelinova®?, is created through a unique, transparent process which involves collecting pre-consumer recycled leather and then hydro-jetting the leather fibers into the TENCEL™? Lanocell fibers, a standout material within the TENCEL™? brand portfolio that is produced from a resource-saving, closed-loop production process. TENCEL™? Liocell fibers are also unfavorable to odor-causing bacteria. The combined efforts between Lenzing and Recyc Leather result in a material which is supple, flexible, and durable, with a low environmental impact utilizing 70% less water than traditional methods and reducing CO2 emissions. Riding on this exciting breakthrough in footwear, Recyc Leather is also exploring the possibility of expanding the fabric application to other leather goods spanning home textiles, furniture, automobile interiors and the luxury segment. Elevating the GANNI partnership: GANNI is a B Corp. certified company, on a journey to become the most responsible version of itself. They believe it's a moral obligation to do better every day. GANNI is committed to minimizing social and environmental impact within its business operation with a goal to reach 50% absolute carbon reduction by 2027, with materials and innovation among its key pillars in reaching this target. In addition to footwear, GANNI sees the application of Recyc Leather's Pelinova®? with TENCEL™? Lycell fibers in the accessories category. GANNI, Recyc Leather, and Lenzing have future developments in the pipeline to get even closer to being able to scale the use of the material. During Premiere Vision Paris (PV Paris, February 6-8), Lenzing will be joined by Recyc Leather and GANNI at a panel discussion to share their collaborative experiences as a prime example of how companies can unite to create high-end fashion using responsibly produced recycled materials. For more interactive participation, visit the TENCEL™? brands at Booth 6D67 and Recyc Leather at Booth 6HUB11. Savings consider solvent recovery. The responsible production of TENCEL™? LTokcell and Modal fibers uses at least 50% less water and emits at least 50% less water. The responsible production of TENEL™? Lyocell and Modal fibers uses At least 50% less water and emissions at least 50% less water, and emits at least 50% more water.Major Estimate Revision • Jan 25Consensus EPS estimates fall by 59%The consensus outlook for fiscal year 2023 has been updated. 2023 expected loss increased from -€4.24 to -€6.73 per share. Revenue forecast unchanged at €2.46b. Chemicals industry in Austria expected to see average net income growth of 1.1% next year. Consensus price target down from €43.60 to €40.80. Share price was steady at €30.00 over the past week.분석 기사 • Jan 04Lenzing Aktiengesellschaft's (VIE:LNZ) Low P/S No Reason For ExcitementWhen you see that almost half of the companies in the Chemicals industry in Austria have price-to-sales ratios (or...Major Estimate Revision • Dec 29Consensus EPS estimates fall by 19%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from €2.51b to €2.46b. Losses expected to increase from €3.58 per share to €4.24. Chemicals industry in Austria expected to see average net income growth of 3.9% next year. Consensus price target down from €44.60 to €43.60. Share price fell 2.3% to €35.55 over the past week.분석 기사 • Nov 10Is Lenzing (VIE:LNZ) Using Debt In A Risky Way?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...New Risk • Nov 07New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (5.4% average weekly change). Minor Risk Shareholders have been diluted in the past year (45% increase in shares outstanding).Reported Earnings • Nov 05Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: €0.97 loss per share (further deteriorated from €0.20 loss in 3Q 2022). Revenue: €615.5m (down 9.0% from 3Q 2022). Net loss: €44.3m (loss widened €39.0m from 3Q 2022). Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) also missed analyst estimates by 14%. Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.Major Estimate Revision • Oct 12Consensus estimates of losses per share improve by 14%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has improved. 2023 revenue forecast increased from €2.52b to €2.56b. EPS estimate increased from -€2.96 per share to -€2.55 per share. Chemicals industry in Austria expected to see average net income growth of 4.3% next year. Consensus price target of €50.83 unchanged from last update. Share price rose 4.0% to €38.05 over the past week.공시 • Aug 22+ 4 more updatesLenzing Aktiengesellschaft to Report Q3, 2024 Results on Nov 07, 2024Lenzing Aktiengesellschaft announced that they will report Q3, 2024 results on Nov 07, 2024Price Target Changed • Aug 04Price target decreased by 7.7% to €57.24Down from €62.04, the current price target is an average from 5 analysts. New target price is 33% above last closing price of €42.95. Stock is down 48% over the past year. The company is forecast to post a net loss per share of €2.80 next year compared to a net loss per share of €2.75 last year.Reported Earnings • Aug 03Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2023 results: €0.89 loss per share (down from €1.49 profit in 2Q 2022). Revenue: €627.1m (down 7.6% from 2Q 2022). Net loss: €23.7m (down 160% from profit in 2Q 2022). Revenue missed analyst estimates by 21%. Earnings per share (EPS) exceeded analyst estimates by 7.3%. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 2.9% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.New Risk • Jul 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 45% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (7.1% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 171% Paying a dividend despite having no free cash flows. Minor Risk Shareholders have been diluted in the past year (45% increase in shares outstanding).공시 • Jul 07Lenzing Aktiengesellschaft has completed a Follow-on Equity Offering in the amount of €399.456758 million.Lenzing Aktiengesellschaft has completed a Follow-on Equity Offering in the amount of €399.456758 million. Security Name: Shares Security Type: Common Stock Securities Offered: 12,068,180 Price\Range: €33.1 Transaction Features: Rights Offering분석 기사 • Jun 16Is Lenzing (VIE:LNZ) Using Debt In A Risky Way?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • May 03First quarter 2023 earnings: EPS and revenues miss analyst expectationsFirst quarter 2023 results: €3.03 loss per share (down from €0.87 profit in 1Q 2022). Revenue: €623.1m (up 1.3% from 1Q 2022). Net loss: €80.5m (down 450% from profit in 1Q 2022). Revenue missed analyst estimates by 2.0%. Earnings per share (EPS) also missed analyst estimates by 73%. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Major Estimate Revision • Mar 26Consensus EPS estimates fall by 121%The consensus outlook for fiscal year 2023 has been updated. 2023 expected loss increased from -€0.18 to -€0.397 per share. Revenue forecast unchanged at €2.65b. Chemicals industry in Austria expected to see average net income decline 2.1% next year. Consensus price target up from €60.80 to €65.04. Share price fell 4.6% to €61.90 over the past week.분석 기사 • Mar 22Lenzing Aktiengesellschaft's (VIE:LNZ) Intrinsic Value Is Potentially 81% Above Its Share PriceKey Insights Using the 2 Stage Free Cash Flow to Equity, Lenzing fair value estimate is €117 Current share price of...Major Estimate Revision • Mar 16Consensus EPS estimates fall from profit to €0.18 lossThe consensus outlook for fiscal year 2023 has been updated. Expected to report loss instead of -€0.18 instead of €0.088 per share profit previously forecast. Revenue forecast unchanged at €2.64b Chemicals industry in Austria expected to see average net income decline 0.3% next year. Consensus price target of €60.80 unchanged from last update. Share price fell 10% to €64.80 over the past week.Reported Earnings • Mar 12Full year 2022 earnings released: €2.75 loss per share (vs €4.16 profit in FY 2021)Full year 2022 results: €2.75 loss per share (down from €4.16 profit in FY 2021). Revenue: €2.57b (up 17% from FY 2021). Net loss: €73.1m (down 166% from profit in FY 2021). Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 2.4% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.Price Target Changed • Mar 09Price target decreased by 18% to €60.80Down from €74.30, the current price target is an average from 5 analysts. New target price is 16% below last closing price of €72.30. Stock is down 19% over the past year. The company is forecast to post a net loss per share of €1.07 compared to earnings per share of €4.16 last year.Major Estimate Revision • Mar 01Consensus EPS estimates fall by 74%The consensus outlook for fiscal year 2022 has been updated. 2022 expected loss increased from -€0.442 to -€0.77 per share. Revenue forecast unchanged at €2.49b. Chemicals industry in Austria expected to see average net income growth of 0.2% next year. Consensus price target broadly unchanged at €74.64. Share price was steady at €70.50 over the past week.분석 기사 • Feb 15Here's Why Lenzing (VIE:LNZ) Is Weighed Down By Its Debt LoadLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Feb 02Is There Now An Opportunity In Lenzing Aktiengesellschaft (VIE:LNZ)?Lenzing Aktiengesellschaft ( VIE:LNZ ), is not the largest company out there, but it received a lot of attention from a...분석 기사 • Jan 20Capital Allocation Trends At Lenzing (VIE:LNZ) Aren't IdealTo find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...Valuation Update With 7 Day Price Move • Jan 04Investor sentiment improved over the past weekAfter last week's 20% share price gain to €65.80, the stock trades at a forward P/E ratio of 577x. Average forward P/E is 16x in the Chemicals industry in Europe. Total loss to shareholders of 16% over the past three years.Major Estimate Revision • Dec 21Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from €0.87 to €0.23 per share. Revenue forecast steady at €2.54b. Net income forecast to shrink 83% next year vs 2.5% decline forecast for Chemicals industry in Austria. Consensus price target of €73.90 unchanged from last update. Share price fell 15% to €56.50 over the past week.Valuation Update With 7 Day Price Move • Dec 20Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €54.20, the stock trades at a forward P/E ratio of 91x. Average forward P/E is 16x in the Chemicals industry in Europe. Total loss to shareholders of 33% over the past three years.Major Estimate Revision • Nov 16Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from €1.63 to €0.95 per share. Revenue forecast steady at €2.54b. Net income forecast to shrink 71% next year vs 2.8% growth forecast for Chemicals industry in Austria . Consensus price target down from €78.30 to €73.90. Share price was steady at €68.40 over the past week.Reported Earnings • Nov 05Third quarter 2022 earnings released: €0.20 loss per share (vs €0.71 profit in 3Q 2021)Third quarter 2022 results: €0.20 loss per share (down from €0.71 profit in 3Q 2021). Revenue: €676.5m (up 22% from 3Q 2021). Net loss: €5.30m (down 128% from profit in 3Q 2021). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 2.5% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to €55.60, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 15x in the Chemicals industry in Europe. Total loss to shareholders of 38% over the past three years.공시 • Nov 03Lenzing AG Appoints Nico Reiner as Chief Financial OfficerThe Supervisory Board of Lenzing AG, has appointed Nico Reiner as its new Chief Financial Officer. Mr. Reiner will join Lenzing's Managing Board led by Chief Executive Officer Stephan Sielaff on January 1, 2023. He will succeed Chief Financial Officer Thomas Obendrauf, who is leaving the company of his own volition after seven years. Nico Reiner has held several positions in his professional career to date, including CFO at globally operating companies such as Schüco Group, AL-KO Group and Pfleiderer Group, as well as management consultant roles. His most recent appointment was as CFO of Vacuumschmelze GmbH & Co. KG, a global player with headquarters in Hanau that specializes in the development, production and marketing of magnetic materials. Born in Grünwald near Munich, Mr. Reiner graduated from the University of Regensburg with a degree in business administration and has a doctorate from HHL Leipzig Graduate School of Management. Chief Financial Officer Thomas Obendrauf notified the Supervisory Board in March that he would not be extending his contract when it came to an end inJune 2022 as after seven years at Lenzing, he is leaving to pursue a career change. Until Mr. Reiner joins the company, Stephan Sielaff will continue to assume the role of CFO on an interim basis, with Mr. Obendrauf supporting the company in an advisory capacity.공시 • Oct 28+ 4 more updatesLenzing Aktiengesellschaft to Report Q3, 2023 Results on Nov 03, 2023Lenzing Aktiengesellschaft announced that they will report Q3, 2023 results on Nov 03, 2023CEOLenzing에는 CEO가 없거나 해당 데이터가 없습니다.리더십 팀이름직위재임 기간보수지분Christian SkilichChief Pulp & Technology Officer and Member of Management Board5.9yrs€1.29m데이터 없음Mathias BreuerCFO & Member of Management Boardless than a year데이터 없음데이터 없음Georg KasperkovitzCOO & Member of Management Boardless than a year데이터 없음데이터 없음Milena IovevaVice President-Corporate Communicationsno data데이터 없음데이터 없음Florian WirthVice President of Legalno data데이터 없음데이터 없음Johann HuberManaging Director of Plasticsno data데이터 없음데이터 없음Sebastien KnusVice President of Capital Marketsno data데이터 없음데이터 없음더 보기0.9yrs평균 재임 기간57yo평균 나이경험이 풍부한 관리: LNZ의 경영진은 경험이 부족한 것으로 간주됩니다(평균 재임 0.9 년) — 신규 팀일 수 있습니다.이사회 구성원이름직위재임 기간보수지분Franz GasselsbergerIndependent Member of Supervisory Board13.1yrs€105.00k데이터 없음Helmut BernkopfIndependent Member of Supervisory Board17.1yrs€69.00k데이터 없음Carlos Anibal de AlmeidaFirst Deputy Chairman of Supervisory Board1.6yrs€35.00k데이터 없음Astrid Skala-KuhmannIndependent Member of Supervisory Board14.1yrs€138.00k데이터 없음Helmut KirchmairEmployee Representative Member of the Supervisory Board10.7yrs데이터 없음데이터 없음Stefan FidaIndependent Second Deputy Chairman of Supervisory Board7.1yrs€143.00k데이터 없음Markus FurstMember of Supervisory Boardno data€66.00k데이터 없음Cornelius BaurMember of the Supervisory Board2.1yrs€96.00k데이터 없음Gerhard SchwartzMember of Supervisory Board3.1yrs€187.00k데이터 없음Stephan GruberEmployee Representative Member of Supervisory Board3.1yrs데이터 없음데이터 없음Bonita HaagEmployee Representative Member of Supervisory Board3.1yrs데이터 없음데이터 없음Stefan ErtlMember of the Supervisory Board2.1yrs데이터 없음데이터 없음더 보기3.1yrs평균 재임 기간58yo평균 나이경험이 풍부한 이사회: LNZ의 이사회는 경험이 있음으로 간주됩니다(평균 재임 3.1 년).View Ownership기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 06:31종가2026/05/21 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Lenzing Aktiengesellschaft는 10명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Sebastian BrayBerenbergFabio LopesBofA Global ResearchLars Vom-CleffDeutsche Bank7명의 분석가 더 보기
공시 • Dec 09Lenzing Aktiengesellschaft, Annual General Meeting, Apr 23, 2026Lenzing Aktiengesellschaft, Annual General Meeting, Apr 23, 2026.
공시 • Apr 18Lenzing Announces Supervisory Board ChangesLenzing at its annual general meeting, appointed Patrick Lackenbucher and Leonardo Grimaldi to the supervisory board until 2029. They replace Cord Prinzhorn, whose term expired, and Marcelo Feriozzi Bacci, who resigned from the board in December 2024, according to a company statement on Thursday.
공시 • Apr 03The Lenzing Group Announces Board Member and Chief Transformation Officer Walter Bickel Will Leave Company At the End of March 2025The Lenzing Group announced personnel changes in the company’s Managing Board. The Supervisory Board of Lenzing AG and Dr. Walter Bickel, Chief Transformation Officer of Lenzing AG, have mutually agreed to end the temporary mandate of Mr. Bickel and that Mr. Bickel will step down from his operational activities at the end of March 2025. Mr. Bickel was appointed to the Managing Board of Lenzing AG as of April 15, 2024 to strengthen the Lenzing Managing Board and to be responsible for the further development and implementation of the performance program. Under his leadership, a significant overachievement of the planned contributions from the performance program could be realized. The basis for future significant improvement steps is established, and the program has been structured in a way that it can now be continued by Lenzing AG seamlessly.
공시 • Mar 12Cord Prinzhorn Not Stand for Re-Election as Member of Lenzing AG's Supervisory BoardThe Chairman of the Supervisory Board of Lenzing AG, Cord Prinzhorn, has informed the Nomination Committee of the Supervisory Board that he will not extend his term as a member of the company’s Supervisory Board after the Annual General Meeting on April 17, 2025 and will not stand for re-election at the upcoming Annual General Meeting. Cord Prinzhorn intends to devote more time to his existing and new activities at the B&C Group. Mr. Prinzhorn will thus leave the Supervisory Board of Lenzing AG at the end of the Annual General Meeting.
공시 • Jan 27Lenzing Aktiengesellschaft, Annual General Meeting, Apr 17, 2025Lenzing Aktiengesellschaft, Annual General Meeting, Apr 17, 2025.
공시 • Aug 22Lenzing Aktiengesellschaft Announces CEO ChangesLenzing Aktiengesellschaft announced Stephan Sielaff to leave the company as of August 31, 2024. Rohit Aggarwal will take over the position of CEO as of 1 September 2024. Outgoing Chief Executive Officer Stephan Sielaff will leave the company end of August 2024, by mutual agreement with the Supervisory Board.
New Risk • May 11New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €215m Forecast net loss in 2 years: €37m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€37m net loss in 2 years). Share price has been volatile over the past 3 months (6.8% average weekly change).
Reported Earnings • May 11First quarter 2026 earnings released: EPS: €0.01 (vs €0.12 in 1Q 2025)First quarter 2026 results: EPS: €0.01 (down from €0.12 in 1Q 2025). Revenue: €615.7m (down 11% from 1Q 2025). Net income: €300.0k (down 94% from 1Q 2025). Profit margin: 0% (down from 0.7% in 1Q 2025). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.
Price Target Changed • Apr 07Price target decreased by 10.0% to €23.50Down from €26.10, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of €23.05. Stock is down 4.4% over the past year. The company is forecast to post a net loss per share of €1.83 next year compared to a net loss per share of €5.45 last year.
Reported Earnings • Mar 20Full year 2025 earnings released: €5.45 loss per share (vs €4.06 loss in FY 2024)Full year 2025 results: €5.45 loss per share (further deteriorated from €4.06 loss in FY 2024). Revenue: €2.60b (down 2.3% from FY 2024). Net loss: €210.3m (loss widened 34% from FY 2024). Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.
Major Estimate Revision • Feb 18Consensus EPS estimates fall by 16%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€3.34 to -€3.88 per share. Revenue forecast unchanged at €2.62b. Chemicals industry in Austria expected to see average net income growth of 29% next year. Consensus price target broadly unchanged at €26.10. Share price fell 5.8% to €26.10 over the past week.
Breakeven Date Change • Feb 17No longer forecast to breakevenThe 5 analysts covering Lenzing no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of €49.9m in 2027. New consensus forecast suggests the company will make a loss of €60.8m in 2027.
공시 • Feb 03Lenzing Aktiengesellschaft (WBAG:LNZ) acquired an additional unknown minority stake in TreeToTextile AB.Lenzing Aktiengesellschaft (WBAG:LNZ) acquired an additional unknown minority stake in TreeToTextile AB on February 2, 2026. The transaction is executed through the issuance of new shares. After the acquisition Lenzing Aktiengesellschaft will own majority stake in TreeToTextile AB. Lenzing Aktiengesellschaft (WBAG:LNZ) completed the acquisition of additional unknown minority stake in TreeToTextile AB on February 2, 2026.
Price Target Changed • Dec 29Price target decreased by 11% to €24.50Down from €27.40, the current price target is an average from 4 analysts. New target price is 8.9% above last closing price of €22.50. Stock is down 24% over the past year. The company is forecast to post a net loss per share of €3.34 next year compared to a net loss per share of €4.06 last year.
공시 • Dec 09Lenzing Aktiengesellschaft, Annual General Meeting, Apr 23, 2026Lenzing Aktiengesellschaft, Annual General Meeting, Apr 23, 2026.
Major Estimate Revision • Oct 01Consensus EPS estimates fall by 38%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€1.37 to -€1.89 per share. Revenue forecast of €2.69b unchanged since last update. Chemicals industry in Austria expected to see average net income growth of 17% next year. Consensus price target broadly unchanged at €28.20. Share price fell 3.7% to €25.80 over the past week.
공시 • Sep 02+ 3 more updatesLenzing Aktiengesellschaft to Report Q1, 2026 Results on May 07, 2026Lenzing Aktiengesellschaft announced that they will report Q1, 2026 results on May 07, 2026
Major Estimate Revision • Aug 15Consensus EPS estimates fall by 12%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€0.988 to -€1.10 per share. Revenue forecast unchanged at €2.69b. Chemicals industry in Austria expected to see average net income growth of 25% next year. Consensus price target broadly unchanged at €28.60. Share price fell 5.5% to €26.75 over the past week.
Price Target Changed • Aug 12Price target decreased by 8.9% to €28.50Down from €31.28, the current price target is an average from 5 analysts. New target price is 7.5% above last closing price of €26.50. Stock is down 13% over the past year. The company is forecast to post a net loss per share of €1.16 next year compared to a net loss per share of €4.06 last year.
Reported Earnings • Aug 08Second quarter 2025 earnings released: €1.02 loss per share (vs €1.01 loss in 2Q 2024)Second quarter 2025 results: €1.02 loss per share (further deteriorated from €1.01 loss in 2Q 2024). Revenue: €650.9m (flat on 2Q 2024). Net loss: €39.4m (loss widened 1.0% from 2Q 2024). Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 31% per year and the company’s share price has also fallen by 31% per year.
분석 기사 • Aug 01Returns On Capital At Lenzing (VIE:LNZ) Paint A Concerning PictureDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
Major Estimate Revision • Jul 09Consensus EPS estimates fall by 18%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€0.835 to -€0.988 per share. Revenue forecast unchanged at €2.69b. Chemicals industry in Austria expected to see average net income growth of 20% next year. Consensus price target broadly unchanged at €30.95. Share price rose 2.8% to €25.50 over the past week.
분석 기사 • Jul 09Lenzing Aktiengesellschaft's (VIE:LNZ) Low P/S No Reason For ExcitementWhen close to half the companies operating in the Chemicals industry in Austria have price-to-sales ratios (or "P/S...
Price Target Changed • Jul 08Price target decreased by 7.5% to €30.95Down from €33.45, the current price target is an average from 6 analysts. New target price is 23% above last closing price of €25.10. Stock is down 24% over the past year. The company is forecast to post a net loss per share of €0.99 next year compared to a net loss per share of €4.06 last year.
Major Estimate Revision • Jun 17Consensus EPS estimates fall by 38%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€0.604 to -€0.835 per share. Revenue forecast unchanged at €2.70b. Chemicals industry in Austria expected to see average net income growth of 18% next year. Consensus price target down from €33.45 to €31.28. Share price fell 12% to €23.75 over the past week.
분석 기사 • Jun 12Does Lenzing (VIE:LNZ) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Major Estimate Revision • Jun 01Consensus EPS estimates fall by 25%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€0.484 to -€0.604 per share. Revenue forecast unchanged at €2.72b. Chemicals industry in Austria expected to see average net income growth of 17% next year. Consensus price target of €33.45 unchanged from last update. Share price was steady at €26.40 over the past week.
Reported Earnings • May 13First quarter 2025 earnings released: EPS: €0.12 (vs €0.83 loss in 1Q 2024)First quarter 2025 results: EPS: €0.12 (up from €0.83 loss in 1Q 2024). Revenue: €690.2m (up 4.8% from 1Q 2024). Net income: €4.70m (up €36.7m from 1Q 2024). Profit margin: 0.7% (up from net loss in 1Q 2024). Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 30% per year, which means it has not declined as severely as earnings.
공시 • Apr 18Lenzing Announces Supervisory Board ChangesLenzing at its annual general meeting, appointed Patrick Lackenbucher and Leonardo Grimaldi to the supervisory board until 2029. They replace Cord Prinzhorn, whose term expired, and Marcelo Feriozzi Bacci, who resigned from the board in December 2024, according to a company statement on Thursday.
분석 기사 • Apr 14Returns On Capital Signal Tricky Times Ahead For Lenzing (VIE:LNZ)If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...
공시 • Apr 03The Lenzing Group Announces Board Member and Chief Transformation Officer Walter Bickel Will Leave Company At the End of March 2025The Lenzing Group announced personnel changes in the company’s Managing Board. The Supervisory Board of Lenzing AG and Dr. Walter Bickel, Chief Transformation Officer of Lenzing AG, have mutually agreed to end the temporary mandate of Mr. Bickel and that Mr. Bickel will step down from his operational activities at the end of March 2025. Mr. Bickel was appointed to the Managing Board of Lenzing AG as of April 15, 2024 to strengthen the Lenzing Managing Board and to be responsible for the further development and implementation of the performance program. Under his leadership, a significant overachievement of the planned contributions from the performance program could be realized. The basis for future significant improvement steps is established, and the program has been structured in a way that it can now be continued by Lenzing AG seamlessly.
Major Estimate Revision • Apr 02Consensus EPS estimates upgraded to €0.49 lossThe consensus outlook for fiscal year 2025 has been updated. 2025 losses forecast to reduce from -€0.64 to -€0.487 per share. Revenue forecast steady at €2.72b. Chemicals industry in Austria expected to see average net income growth of 17% next year. Consensus price target broadly unchanged at €32.95. Share price fell 15% to €25.90 over the past week.
분석 기사 • Mar 15Lenzing Aktiengesellschaft (VIE:LNZ) Surges 35% Yet Its Low P/S Is No Reason For ExcitementLenzing Aktiengesellschaft ( VIE:LNZ ) shares have had a really impressive month, gaining 35% after a shaky period...
Reported Earnings • Mar 14Full year 2024 earnings released: €4.06 loss per share (vs €20.02 loss in FY 2023)Full year 2024 results: €4.06 loss per share (improved from €20.02 loss in FY 2023). Revenue: €2.66b (up 5.7% from FY 2023). Net loss: €156.6m (loss narrowed 76% from FY 2023). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 50 percentage points per year, which is a significant difference in performance.
공시 • Mar 12Cord Prinzhorn Not Stand for Re-Election as Member of Lenzing AG's Supervisory BoardThe Chairman of the Supervisory Board of Lenzing AG, Cord Prinzhorn, has informed the Nomination Committee of the Supervisory Board that he will not extend his term as a member of the company’s Supervisory Board after the Annual General Meeting on April 17, 2025 and will not stand for re-election at the upcoming Annual General Meeting. Cord Prinzhorn intends to devote more time to his existing and new activities at the B&C Group. Mr. Prinzhorn will thus leave the Supervisory Board of Lenzing AG at the end of the Annual General Meeting.
New Risk • Feb 15New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Austrian stocks, typically moving 6.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (6.0% average weekly change).
공시 • Jan 27Lenzing Aktiengesellschaft, Annual General Meeting, Apr 17, 2025Lenzing Aktiengesellschaft, Annual General Meeting, Apr 17, 2025.
분석 기사 • Jan 14Is Lenzing (VIE:LNZ) A Risky Investment?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
New Risk • Dec 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Austrian stocks, typically moving 4.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (4.6% average weekly change).
분석 기사 • Dec 06Investors Don't See Light At End Of Lenzing Aktiengesellschaft's (VIE:LNZ) TunnelWhen you see that almost half of the companies in the Chemicals industry in Austria have price-to-sales ratios (or...
Major Estimate Revision • Nov 14Consensus EPS estimates fall by 34%The consensus outlook for fiscal year 2024 has been updated. 2024 expected loss increased from -€2.63 to -€3.51 per share. Revenue forecast unchanged at €2.66b. Chemicals industry in Austria expected to see average net income growth of 35% next year. Consensus price target broadly unchanged at €33.74. Share price fell 5.6% to €29.75 over the past week.
Reported Earnings • Nov 08Third quarter 2024 earnings released: €1.66 loss per share (vs €0.97 loss in 3Q 2023)Third quarter 2024 results: €1.66 loss per share (further deteriorated from €0.97 loss in 3Q 2023). Revenue: €647.5m (up 5.2% from 3Q 2023). Net loss: €64.1m (loss widened 45% from 3Q 2023). Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.
공시 • Nov 06Lenzing Nonwovens Expands its LENZING Lyocell Dry Fiber Portfolio to Offer Cellulosic Solutions for a Wider Range of ApplicationsLenzing Nonwovens announced the expansion of its LENZING Lyocell Dry fiber portfolio with two new cellulosic fibers – a fine dry fiber that delivers strength and softness and a coarse dry fiber which provides enhanced liquid and air flow. These two innovative products enable customers to confidently broaden their use of LENZING's wood-based and biodegradable fibers into a wider range of applications while maintaining exceptional performance. All LENZING Lyocell Dry fibers within the family (standard, fine, and coarse) have hydrophobic properties which ensure efficient liquid management suitable for extensive nonwoven applications. The new LENZING Lyocell Dry fine fiber can produce nonwoven fabrics with higher density compared to LENZING Lyocell Dry standard fiber. With up to 30% more cellulosic fibers in the same space, customers can create strong and soft nonwoven products. These fibers are suitable for use in hygiene applications such as diapers or sanitary pads. The new LENZING Lyocell Dry coarse fiber creates fabrics that are more open due to its extended fiber diameter, and thus increasing the pore sizes between the fibers in the fabric. This allows for more air or liquid to flow through the material. It is particularly suitable for the acquisition and distribution layer in hygiene products and is also being explored for industrial filtration applications. Lenzing will showcase its innovative LENZING Lyocell Dry fiber family at tabletop 202 during the Hygienix Conference, November 18-21, 2024. Facts and figures: LENZING Lyocell Dry fine has a linear density of 1.3dtex; LENZING Lyocell Dry standard has a linear density of 1.7dtex; Fabrics produced using LENZING Lyocell Dry fine and standard have the same basis weight (eg. 50gsm) but the "fine" material has a higher density with up to 30% more fibers in the same space. LENZING Lyocell Dry coarse has a linear density of 6.3dtex.
분석 기사 • Nov 01Lenzing (VIE:LNZ) Might Be Having Difficulty Using Its Capital EffectivelyWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
공시 • Oct 17+ 2 more updatesLenzing Aktiengesellschaft to Report Q3, 2025 Results on Nov 06, 2025Lenzing Aktiengesellschaft announced that they will report Q3, 2025 results on Nov 06, 2025
분석 기사 • Sep 20Is Lenzing (VIE:LNZ) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Major Estimate Revision • Sep 01Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2024 has been updated. 2024 expected loss increased from -€1.87 to -€2.07 per share. Revenue forecast unchanged at €2.65b. Chemicals industry in Austria expected to see average net income growth of 30% next year. Consensus price target broadly unchanged at €34.04. Share price fell 3.0% to €30.85 over the past week.
공시 • Aug 22Lenzing Aktiengesellschaft Announces CEO ChangesLenzing Aktiengesellschaft announced Stephan Sielaff to leave the company as of August 31, 2024. Rohit Aggarwal will take over the position of CEO as of 1 September 2024. Outgoing Chief Executive Officer Stephan Sielaff will leave the company end of August 2024, by mutual agreement with the Supervisory Board.
Major Estimate Revision • Aug 14Consensus EPS estimates fall by 29%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from €2.63b to €2.66b. Forecast EPS reduced from -€1.46 to -€1.87 per share. Chemicals industry in Austria expected to see average net income growth of 30% next year. Consensus price target broadly unchanged at €34.06. Share price was steady at €30.45 over the past week.
Reported Earnings • Aug 08Second quarter 2024 earnings released: €1.01 loss per share (vs €0.89 loss in 2Q 2023)Second quarter 2024 results: €1.01 loss per share (further deteriorated from €0.89 loss in 2Q 2023). Revenue: €652.3m (up 4.0% from 2Q 2023). Net loss: €39.0m (loss widened 65% from 2Q 2023). Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance.
분석 기사 • Jul 16Lenzing Aktiengesellschaft's (VIE:LNZ) Share Price Is Matching Sentiment Around Its RevenuesLenzing Aktiengesellschaft's ( VIE:LNZ ) price-to-sales (or "P/S") ratio of 0.5x may look like a pretty appealing...
분석 기사 • Jun 09Lenzing (VIE:LNZ) Has Debt But No Earnings; Should You Worry?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Price Target Changed • May 14Price target increased by 9.6% to €34.26Up from €31.26, the current price target is an average from 5 analysts. New target price is 5.2% below last closing price of €36.15. Stock is down 34% over the past year. The company is forecast to post a net loss per share of €1.46 next year compared to a net loss per share of €20.02 last year.
Reported Earnings • May 09First quarter 2024 earnings released: €0.83 loss per share (vs €3.03 loss in 1Q 2023)First quarter 2024 results: €0.83 loss per share (improved from €3.03 loss in 1Q 2023). Revenue: €658.4m (up 5.7% from 1Q 2023). Net loss: €32.0m (loss narrowed 60% from 1Q 2023). Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
분석 기사 • Apr 16Lenzing Aktiengesellschaft (VIE:LNZ) Stock Catapults 26% Though Its Price And Business Still Lag The IndustryLenzing Aktiengesellschaft ( VIE:LNZ ) shares have had a really impressive month, gaining 26% after a shaky period...
Major Estimate Revision • Mar 22Consensus EPS estimates fall by 138%The consensus outlook for fiscal year 2024 has been updated. 2024 expected loss increased from -€0.659 to -€1.57 per share. Revenue forecast unchanged at €2.58b. Chemicals industry in Austria expected to see average net income growth of 19% next year. Consensus price target down from €36.21 to €32.26. Share price was steady at €30.10 over the past week.
Price Target Changed • Mar 18Price target decreased by 17% to €32.66Down from €39.20, the current price target is an average from 5 analysts. New target price is 31% above last closing price of €24.85. Stock is down 60% over the past year. The company is forecast to post a net loss per share of €0.30 next year compared to a net loss per share of €20.02 last year.
Reported Earnings • Mar 15Full year 2023 earnings released: €20.02 loss per share (vs €2.75 loss in FY 2022)Full year 2023 results: €20.02 loss per share (further deteriorated from €2.75 loss in FY 2022). Revenue: €2.52b (down 1.7% from FY 2022). Net loss: €649.4m (loss widened €576.4m from FY 2022). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.
Price Target Changed • Feb 29Price target decreased by 10% to €36.66Down from €40.80, the current price target is an average from 5 analysts. New target price is 27% above last closing price of €28.95. Stock is down 58% over the past year. The company is forecast to post a net loss per share of €9.69 next year compared to a net loss per share of €2.75 last year.
분석 기사 • Feb 27Is Lenzing (VIE:LNZ) Using Debt In A Risky Way?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Major Estimate Revision • Feb 09Consensus EPS estimates fall by 28%The consensus outlook for fiscal year 2023 has been updated. 2023 expected loss increased from -€7.59 to -€9.69 per share. Revenue forecast of €2.46b unchanged since last update. Chemicals industry in Austria expected to see average net income growth of 14% next year. Consensus price target down from €40.80 to €39.20. Share price fell 6.3% to €28.15 over the past week.
공시 • Feb 01Lenzing Group Teams Up with Recyc Leather and Ganni to Unveil New Footwear MaterialsLenzing Group has partnered with leather alternative expert Recyc Leather to introduce Pelinova, an innovative material that fuses TENCEL™? Lyocell fibers and recycled leather fibers for high-end fashion applications. Joining forces with Danish advanced contemporary brand GANNI, this dynamic trio is set to bring this next-generation material to the market as an alternative to genuine leather materials, starting with GANNI's Slouchy Boots launching early this year. Pelinova: a hybrid alternative combining TENCEL™? L Tokyocell fibers and recycled leather fibers. Recyc Leather's next-generation material, Pelinova®?, is created through a unique, transparent process which involves collecting pre-consumer recycled leather and then hydro-jetting the leather fibers into the TENCEL™? Lanocell fibers, a standout material within the TENCEL™? brand portfolio that is produced from a resource-saving, closed-loop production process. TENCEL™? Liocell fibers are also unfavorable to odor-causing bacteria. The combined efforts between Lenzing and Recyc Leather result in a material which is supple, flexible, and durable, with a low environmental impact utilizing 70% less water than traditional methods and reducing CO2 emissions. Riding on this exciting breakthrough in footwear, Recyc Leather is also exploring the possibility of expanding the fabric application to other leather goods spanning home textiles, furniture, automobile interiors and the luxury segment. Elevating the GANNI partnership: GANNI is a B Corp. certified company, on a journey to become the most responsible version of itself. They believe it's a moral obligation to do better every day. GANNI is committed to minimizing social and environmental impact within its business operation with a goal to reach 50% absolute carbon reduction by 2027, with materials and innovation among its key pillars in reaching this target. In addition to footwear, GANNI sees the application of Recyc Leather's Pelinova®? with TENCEL™? Lycell fibers in the accessories category. GANNI, Recyc Leather, and Lenzing have future developments in the pipeline to get even closer to being able to scale the use of the material. During Premiere Vision Paris (PV Paris, February 6-8), Lenzing will be joined by Recyc Leather and GANNI at a panel discussion to share their collaborative experiences as a prime example of how companies can unite to create high-end fashion using responsibly produced recycled materials. For more interactive participation, visit the TENCEL™? brands at Booth 6D67 and Recyc Leather at Booth 6HUB11. Savings consider solvent recovery. The responsible production of TENCEL™? LTokcell and Modal fibers uses at least 50% less water and emits at least 50% less water. The responsible production of TENEL™? Lyocell and Modal fibers uses At least 50% less water and emissions at least 50% less water, and emits at least 50% more water.
Major Estimate Revision • Jan 25Consensus EPS estimates fall by 59%The consensus outlook for fiscal year 2023 has been updated. 2023 expected loss increased from -€4.24 to -€6.73 per share. Revenue forecast unchanged at €2.46b. Chemicals industry in Austria expected to see average net income growth of 1.1% next year. Consensus price target down from €43.60 to €40.80. Share price was steady at €30.00 over the past week.
분석 기사 • Jan 04Lenzing Aktiengesellschaft's (VIE:LNZ) Low P/S No Reason For ExcitementWhen you see that almost half of the companies in the Chemicals industry in Austria have price-to-sales ratios (or...
Major Estimate Revision • Dec 29Consensus EPS estimates fall by 19%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from €2.51b to €2.46b. Losses expected to increase from €3.58 per share to €4.24. Chemicals industry in Austria expected to see average net income growth of 3.9% next year. Consensus price target down from €44.60 to €43.60. Share price fell 2.3% to €35.55 over the past week.
분석 기사 • Nov 10Is Lenzing (VIE:LNZ) Using Debt In A Risky Way?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
New Risk • Nov 07New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (5.4% average weekly change). Minor Risk Shareholders have been diluted in the past year (45% increase in shares outstanding).
Reported Earnings • Nov 05Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: €0.97 loss per share (further deteriorated from €0.20 loss in 3Q 2022). Revenue: €615.5m (down 9.0% from 3Q 2022). Net loss: €44.3m (loss widened €39.0m from 3Q 2022). Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) also missed analyst estimates by 14%. Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
Major Estimate Revision • Oct 12Consensus estimates of losses per share improve by 14%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has improved. 2023 revenue forecast increased from €2.52b to €2.56b. EPS estimate increased from -€2.96 per share to -€2.55 per share. Chemicals industry in Austria expected to see average net income growth of 4.3% next year. Consensus price target of €50.83 unchanged from last update. Share price rose 4.0% to €38.05 over the past week.
공시 • Aug 22+ 4 more updatesLenzing Aktiengesellschaft to Report Q3, 2024 Results on Nov 07, 2024Lenzing Aktiengesellschaft announced that they will report Q3, 2024 results on Nov 07, 2024
Price Target Changed • Aug 04Price target decreased by 7.7% to €57.24Down from €62.04, the current price target is an average from 5 analysts. New target price is 33% above last closing price of €42.95. Stock is down 48% over the past year. The company is forecast to post a net loss per share of €2.80 next year compared to a net loss per share of €2.75 last year.
Reported Earnings • Aug 03Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2023 results: €0.89 loss per share (down from €1.49 profit in 2Q 2022). Revenue: €627.1m (down 7.6% from 2Q 2022). Net loss: €23.7m (down 160% from profit in 2Q 2022). Revenue missed analyst estimates by 21%. Earnings per share (EPS) exceeded analyst estimates by 7.3%. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 2.9% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.
New Risk • Jul 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 45% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (7.1% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 171% Paying a dividend despite having no free cash flows. Minor Risk Shareholders have been diluted in the past year (45% increase in shares outstanding).
공시 • Jul 07Lenzing Aktiengesellschaft has completed a Follow-on Equity Offering in the amount of €399.456758 million.Lenzing Aktiengesellschaft has completed a Follow-on Equity Offering in the amount of €399.456758 million. Security Name: Shares Security Type: Common Stock Securities Offered: 12,068,180 Price\Range: €33.1 Transaction Features: Rights Offering
분석 기사 • Jun 16Is Lenzing (VIE:LNZ) Using Debt In A Risky Way?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • May 03First quarter 2023 earnings: EPS and revenues miss analyst expectationsFirst quarter 2023 results: €3.03 loss per share (down from €0.87 profit in 1Q 2022). Revenue: €623.1m (up 1.3% from 1Q 2022). Net loss: €80.5m (down 450% from profit in 1Q 2022). Revenue missed analyst estimates by 2.0%. Earnings per share (EPS) also missed analyst estimates by 73%. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Major Estimate Revision • Mar 26Consensus EPS estimates fall by 121%The consensus outlook for fiscal year 2023 has been updated. 2023 expected loss increased from -€0.18 to -€0.397 per share. Revenue forecast unchanged at €2.65b. Chemicals industry in Austria expected to see average net income decline 2.1% next year. Consensus price target up from €60.80 to €65.04. Share price fell 4.6% to €61.90 over the past week.
분석 기사 • Mar 22Lenzing Aktiengesellschaft's (VIE:LNZ) Intrinsic Value Is Potentially 81% Above Its Share PriceKey Insights Using the 2 Stage Free Cash Flow to Equity, Lenzing fair value estimate is €117 Current share price of...
Major Estimate Revision • Mar 16Consensus EPS estimates fall from profit to €0.18 lossThe consensus outlook for fiscal year 2023 has been updated. Expected to report loss instead of -€0.18 instead of €0.088 per share profit previously forecast. Revenue forecast unchanged at €2.64b Chemicals industry in Austria expected to see average net income decline 0.3% next year. Consensus price target of €60.80 unchanged from last update. Share price fell 10% to €64.80 over the past week.
Reported Earnings • Mar 12Full year 2022 earnings released: €2.75 loss per share (vs €4.16 profit in FY 2021)Full year 2022 results: €2.75 loss per share (down from €4.16 profit in FY 2021). Revenue: €2.57b (up 17% from FY 2021). Net loss: €73.1m (down 166% from profit in FY 2021). Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 2.4% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.
Price Target Changed • Mar 09Price target decreased by 18% to €60.80Down from €74.30, the current price target is an average from 5 analysts. New target price is 16% below last closing price of €72.30. Stock is down 19% over the past year. The company is forecast to post a net loss per share of €1.07 compared to earnings per share of €4.16 last year.
Major Estimate Revision • Mar 01Consensus EPS estimates fall by 74%The consensus outlook for fiscal year 2022 has been updated. 2022 expected loss increased from -€0.442 to -€0.77 per share. Revenue forecast unchanged at €2.49b. Chemicals industry in Austria expected to see average net income growth of 0.2% next year. Consensus price target broadly unchanged at €74.64. Share price was steady at €70.50 over the past week.
분석 기사 • Feb 15Here's Why Lenzing (VIE:LNZ) Is Weighed Down By Its Debt LoadLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
분석 기사 • Feb 02Is There Now An Opportunity In Lenzing Aktiengesellschaft (VIE:LNZ)?Lenzing Aktiengesellschaft ( VIE:LNZ ), is not the largest company out there, but it received a lot of attention from a...
분석 기사 • Jan 20Capital Allocation Trends At Lenzing (VIE:LNZ) Aren't IdealTo find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...
Valuation Update With 7 Day Price Move • Jan 04Investor sentiment improved over the past weekAfter last week's 20% share price gain to €65.80, the stock trades at a forward P/E ratio of 577x. Average forward P/E is 16x in the Chemicals industry in Europe. Total loss to shareholders of 16% over the past three years.
Major Estimate Revision • Dec 21Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from €0.87 to €0.23 per share. Revenue forecast steady at €2.54b. Net income forecast to shrink 83% next year vs 2.5% decline forecast for Chemicals industry in Austria. Consensus price target of €73.90 unchanged from last update. Share price fell 15% to €56.50 over the past week.
Valuation Update With 7 Day Price Move • Dec 20Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €54.20, the stock trades at a forward P/E ratio of 91x. Average forward P/E is 16x in the Chemicals industry in Europe. Total loss to shareholders of 33% over the past three years.
Major Estimate Revision • Nov 16Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from €1.63 to €0.95 per share. Revenue forecast steady at €2.54b. Net income forecast to shrink 71% next year vs 2.8% growth forecast for Chemicals industry in Austria . Consensus price target down from €78.30 to €73.90. Share price was steady at €68.40 over the past week.
Reported Earnings • Nov 05Third quarter 2022 earnings released: €0.20 loss per share (vs €0.71 profit in 3Q 2021)Third quarter 2022 results: €0.20 loss per share (down from €0.71 profit in 3Q 2021). Revenue: €676.5m (up 22% from 3Q 2021). Net loss: €5.30m (down 128% from profit in 3Q 2021). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 2.5% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.
Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to €55.60, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 15x in the Chemicals industry in Europe. Total loss to shareholders of 38% over the past three years.
공시 • Nov 03Lenzing AG Appoints Nico Reiner as Chief Financial OfficerThe Supervisory Board of Lenzing AG, has appointed Nico Reiner as its new Chief Financial Officer. Mr. Reiner will join Lenzing's Managing Board led by Chief Executive Officer Stephan Sielaff on January 1, 2023. He will succeed Chief Financial Officer Thomas Obendrauf, who is leaving the company of his own volition after seven years. Nico Reiner has held several positions in his professional career to date, including CFO at globally operating companies such as Schüco Group, AL-KO Group and Pfleiderer Group, as well as management consultant roles. His most recent appointment was as CFO of Vacuumschmelze GmbH & Co. KG, a global player with headquarters in Hanau that specializes in the development, production and marketing of magnetic materials. Born in Grünwald near Munich, Mr. Reiner graduated from the University of Regensburg with a degree in business administration and has a doctorate from HHL Leipzig Graduate School of Management. Chief Financial Officer Thomas Obendrauf notified the Supervisory Board in March that he would not be extending his contract when it came to an end inJune 2022 as after seven years at Lenzing, he is leaving to pursue a career change. Until Mr. Reiner joins the company, Stephan Sielaff will continue to assume the role of CFO on an interim basis, with Mr. Obendrauf supporting the company in an advisory capacity.
공시 • Oct 28+ 4 more updatesLenzing Aktiengesellschaft to Report Q3, 2023 Results on Nov 03, 2023Lenzing Aktiengesellschaft announced that they will report Q3, 2023 results on Nov 03, 2023